Agios Pharmaceuticals AGIO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$99.11M-11.0% | -$108.04M— | -$103.43M-111% | -$112.02M-16.5% | -$89.29M-9.5% | ||
| $1.36M+6.7% | $1.27M-7.4% | $1.37M+2.2% | $1.26M-21.0% | $1.28M-5.2% | ||
| $15.54M+36.8% | $14.12M+29.5% | $12.38M+11.1% | $14.69M+27.0% | $11.36M+23.0% | ||
| -$118.92M-6.7% | -$96.21M+27.8% | -$88.15M-4.7% | -$77.12M-6.2% | -$111.49M-11.6% | ||
| $769K+0.4% | $1.12M+15.8% | $1.56M+271% | $875K+454% | $766K+443% | ||
| $141.31M+25.5% | $90.08M— | $95.56M-61.9% | $78.97M+112% | $112.59M-9.6% | ||
| $2.08M+28.4% | $2.56M-47.2% | $4.44M+68.2% | $65K-94.1% | $1.62M-72.4% | ||
| $24.47M+801% | —— | $11.84M-93.0% | $1.91M+106% | $2.72M-91.1% | ||
| -$119.69M-6.6% | -$97.33M+27.4% | -$89.71M-6.0% | -$78M-7.2% | -$112.26M-12.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Agios Pharmaceuticals generate?
- Agios Pharmaceuticals (AGIO) generated -$380.4M in operating cash flow over the trailing twelve months.
- What is Agios Pharmaceuticals's free cash flow?
- After $4.3M of capital expenditures, Agios Pharmaceuticals's free cash flow was -$384.7M over the trailing twelve months, up 4.7% year over year.
- Where does Agios Pharmaceuticals's cash flow data come from?
- Every line is extracted from Agios Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
